<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://www.scipedia.com/wd/index.php?action=history&amp;feed=atom&amp;title=Chen_et_al._2016abcdefa</id>
		<title>Chen et al. 2016abcdefa - Revision history</title>
		<link rel="self" type="application/atom+xml" href="https://www.scipedia.com/wd/index.php?action=history&amp;feed=atom&amp;title=Chen_et_al._2016abcdefa"/>
		<link rel="alternate" type="text/html" href="https://www.scipedia.com/wd/index.php?title=Chen_et_al._2016abcdefa&amp;action=history"/>
		<updated>2026-05-10T18:36:24Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.27.0-wmf.10</generator>

	<entry>
		<id>https://www.scipedia.com/wd/index.php?title=Chen_et_al._2016abcdefa&amp;diff=9584&amp;oldid=prev</id>
		<title>Scipediacontent: Scipediacontent moved page Draft Content 874000900 to Chen et al. 2016abcdefa</title>
		<link rel="alternate" type="text/html" href="https://www.scipedia.com/wd/index.php?title=Chen_et_al._2016abcdefa&amp;diff=9584&amp;oldid=prev"/>
				<updated>2016-10-04T10:26:07Z</updated>
		
		<summary type="html">&lt;p&gt;Scipediacontent moved page &lt;a href=&quot;/public/Draft_Content_874000900&quot; class=&quot;mw-redirect&quot; title=&quot;Draft Content 874000900&quot;&gt;Draft Content 874000900&lt;/a&gt; to &lt;a href=&quot;/public/Chen_et_al._2016abcdefa&quot; title=&quot;Chen et al. 2016abcdefa&quot;&gt;Chen et al. 2016abcdefa&lt;/a&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr style='vertical-align: top;' lang='en'&gt;
				&lt;td colspan='1' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan='1' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 10:26, 4 October 2016&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan='2' style='text-align: center;' lang='en'&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Scipediacontent</name></author>	</entry>

	<entry>
		<id>https://www.scipedia.com/wd/index.php?title=Chen_et_al._2016abcdefa&amp;diff=9443&amp;oldid=prev</id>
		<title>Scipediacontent: Created page with &quot;  '''Purpose:'''  In contrast to PSA for prostate cancer, no reliable bladder cancer biomarker is currently widely applicable for the detection and follow-up of bladder cancer...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.scipedia.com/wd/index.php?title=Chen_et_al._2016abcdefa&amp;diff=9443&amp;oldid=prev"/>
				<updated>2016-10-03T13:58:03Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;  &amp;#039;&amp;#039;&amp;#039;Purpose:&amp;#039;&amp;#039;&amp;#039;  In contrast to PSA for prostate cancer, no reliable bladder cancer biomarker is currently widely applicable for the detection and follow-up of bladder cancer...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
'''Purpose:'''  In contrast to PSA for prostate cancer, no reliable bladder cancer biomarker is currently widely applicable for the detection and follow-up of bladder cancer. We employed a strategy combining isotopic dimethylation labeling coupled with liquid chromatography-tandem mass spectrometry (LC−MS/MS) to discover bladder cancer biomarkers in urinary microparticles isolated from hernia (control) and bladder cancer patients.      &lt;br /&gt;
&lt;br /&gt;
'''Materials and Methods:'''  The urine specimens of bladder cancer patients and age-matched hernia patients (n = 81) were collected in the morning of surgery. The surgically resected bladder tumors were all pathologically identified and determined into 3 groups for comparison; namely, Low-grade/Early stage (LgEs, n = 40), High-grade/Early stage (HgEs, n = 63), and High-grade/ Advanced-stage (HgAs, n = 37).      &lt;br /&gt;
&lt;br /&gt;
'''Results:'''  A total of 107 proteins out of 2964 proteins were identified in this approach as candidate biomarkers. Differences in the concentrations of 29 proteins were precisely quantified by LC−MRM/MS. There were 24 proteins changed significantly (''p''  &amp;lt; 0.05) between bladder cancer and hernia. TACSTD2 concentrations measured by LC-MRM/MS were 6.5-fold higher in bladder cancer urinary microparticles than in hernia urinary microparticles. In raw urine specimens (n = 221) using ELISA, the area-under-the-curve values of TACSTD2 was 0.80.      &lt;br /&gt;
&lt;br /&gt;
'''Conclusion:'''  Our study revealed that TACSTD2 showed strong association with bladder canLcer in urine specimens, and thus represents a potential biomarker for noninvasive screening for bladder cancer.&lt;/div&gt;</summary>
		<author><name>Scipediacontent</name></author>	</entry>

	</feed>